Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective β3-Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment?

  • Antimuscarinics and Mirabegron
  • Minoru KOBAYASHI, Akinori NUKUI, Takao KAMAI
  • LUTS Lower Urinary Tract Symptoms, December 2016, Wiley
  • DOI: 10.1111/luts.12153

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/luts.12153

In partnership with: